(NURE) Nuveen Short-Term REIT - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US67092P7069
NURE: Real Estate, REITs, Equity, Investment, Assets
Nuveen Short-Term REIT ETF (BATS:NURE) is an exchange-traded fund that focuses on investing at least 80% of its net assets and borrowings in Real Estate Investment Trusts (REITs) that meet specific criteria. The underlying index is a subset of the Dow Jones U.S. Select REIT Index, comprising equity REITs listed on U.S. national securities exchanges, deriving at least 75% of their revenue from owning and operating real estate assets, and having a minimum market capitalization of $200 million.
The funds investment strategy is centered around REITs that are primarily involved in the ownership and operation of real estate assets, providing a relatively focused exposure to the real estate sector. As a non-diversified fund, NURE may have a higher concentration risk compared to diversified funds, which could result in higher volatility.
Analyzing the
Combining the insights from
To validate this forecast, it is crucial to monitor the funds tracking error, changes in AUM, and shifts in the underlying index composition. Additionally, keeping a close eye on interest rates, real estate market trends, and overall economic conditions will be essential in assessing NUREs future performance.
Additional Sources for NURE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
NURE ETF Overview
Market Cap in USD | 44m |
Category | Real Estate |
TER | 0.35% |
IPO / Inception | 2016-12-19 |
NURE ETF Ratings
Growth Rating | 17.1 |
Fundamental | - |
Dividend Rating | 63.3 |
Rel. Strength | -11.6 |
Analysts | - |
Fair Price Momentum | 28.90 USD |
Fair Price DCF | - |
NURE Dividends
Dividend Yield 12m | 3.62% |
Yield on Cost 5y | 5.70% |
Annual Growth 5y | 7.54% |
Payout Consistency | 82.5% |
Payout Ratio | % |
NURE Growth Ratios
Growth Correlation 3m | 2.9% |
Growth Correlation 12m | -44.8% |
Growth Correlation 5y | 30.5% |
CAGR 5y | 9.20% |
CAGR/Max DD 5y | 0.26 |
Sharpe Ratio 12m | 0.86 |
Alpha | -7.50 |
Beta | 0.582 |
Volatility | 18.49% |
Current Volume | 1.9k |
Average Volume 20d | 4.1k |
As of June 24, 2025, the stock is trading at USD 30.32 with a total of 1,851 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +3.21%, over three months by -2.79% and over the past year by +0.18%.
Neither. Based on ValueRay´s Analyses, Nuveen Short-Term REIT is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 17.13 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NURE is around 28.90 USD . This means that NURE is currently overvalued and has a potential downside of -4.68%.
Nuveen Short-Term REIT has no consensus analysts rating.
According to our own proprietary Forecast Model, NURE Nuveen Short-Term REIT will be worth about 32.2 in June 2026. The stock is currently trading at 30.32. This means that the stock has a potential upside of +6.17%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 32.2 | 6.2% |